The Successful Retreatment with Glecaprevir and Pibrentasvir of Genotype 1 or 2 HCV-infected Hemodialysis Patients who Failed to Respond to NS5A and Protease Inhibitor Treatment
The Successful Retreatment with Glecaprevir and Pibrentasvir of Genotype 1 or 2 HCV-infected Hemodialysis Patients who Failed to Respond to NS5A and Protease Inhibitor Treatment
复制标题
对 NS5A 和蛋白酶抑制剂治疗无反应的基因型 1 或 2 HCV 感染血液透析患者成功使用 Glecaprevir 和 Pibrentasvir 进行再治疗
DOI：
10.2169/internalmedicine.2077-18
复制
发表时间：
2019
影响因子：
1.2
通讯作者：
for t
中科院分区：
文献类型：
--
作者：
Suda Goki;Nakai Masato;Sho Takuya;Kimura Megumi;Shimazaki Tomoe;Maehara Osamu;Shigesawa Taku;Suzuki Kazuharu;Nakamura Akihisa;Ohara Masatsugu;Umemura Machiko;Kawagishi Naoki;Baba Masaru;Natsuizaka Mitsuteru;Morikawa Kenichi;Ogawa Koji;Sakamoto Naoya;for t
